Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy | Zendy

BorShyang Sheu | Zendy; HsiuChi Cheng | Zendy; Ai-Wen Kao | Zendy; ShanTair Wang | Zendy; YaoJong Yang | Zendy; HsiaoBai Yang | Zendy; Jiunn-Jong Wu | Zendy

Open Access

Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy

Author(s) -

BorShyang Sheu,

HsiuChi Cheng,

Ai-Wen Kao,

ShanTair Wang,

YaoJong Yang,

HsiaoBai Yang,

Jiunn-Jong Wu

Publication year - 2006

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn/83.4.864

Subject(s) - breath test , medicine , urea breath test , helicobacter pylori , bifidobacterium , gastroenterology , ingestion , lactobacillus , combination therapy , food science , helicobacter pylori infection , biology , fermentation

Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) can suppress Helicobacter pylori. Improvement of the eradication rate by quadruple therapy of residual H. pylori after failed triple therapy is needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog